Log In
Friday 27th November 2015

Astrazeneca Articles


FDA decline diabetes drugs

16th October 2015

AstraZeneca's fixed combination diabetes drugs have been declined by the US health regulators.

Read All ►

AstraZeneca receives funding for Alzheimer's drug

16th September 2014

AstraZeneca signs partnership deal with US rival Eli Lilly that could earn the British company up to $500m.

Read All ►

AstraZeneca sees off Pfizer

31st July 2014

AstraZeneca has raised its sales and earnings forecasts after seeing off Pfizer's takeover approach.

Read All ►

Pfizer faces second day of grillling by MPs

14th May 2014

Fresh questions for chief executive of Pfizer in AstraZeneca takeover.

Read All ►

Pfizer's pledge 'vague' and insufficient

13th May 2014

Professor says Pfizer's commitments should it take over AstraZeneca are 'vague'.

Read All ►

Pfizer raises bid for AstraZeneca

2nd May 2014

Pfizer has raised the price it is offering for AstraZeneca after initial offer was rejected.

Read All ►

AstraZeneca highlight progress with new cancer drugs

24th April 2014

AstraZeneca flags cancer advances as it posted a 17% fall in core earnings per share.

Read All ►

AstraZeneca signs deal with Immunocore

8th January 2014

AstraZeneca has signed a deal with Immunocore to boost experimental cancer drug pipeline.

Read All ►

AstraZeneca hope for new heart drug approval

18th September 2013

An experimental fish oil-based drug has been accepted by US regulators for review.

Read All ►

Heads of research removed from AstraZeneca

16th January 2013

New CEO of AstraZeneca has removed heads of research from struggling drugmaker.

Read All ►

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2015